Vaish Ritu, Pradeep Mss, Setty C R, Kandi Venkataramana
Department of Microbiology, Prathima Institute of Medical Sciences.
Department of Microbiology, Dr. Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation.
Cureus. 2016 May 9;8(5):e604. doi: 10.7759/cureus.604.
Identification of virulence determinants among the clinically isolated microorganisms assumes greater significance in the patient management perspective. Among the hospitalized patients, extremes of age groups (neonatal and geriatric age patients), patients who are debilitated due to other associated medical conditions, patients taking immunosuppressive therapy, and patients undergoing major surgeries are prone to infections with previously nonpathogenic or opportunistic pathogens. Screening of the pathogenic potential of such bacteria and identifying their virulence factors and antimicrobial susceptibility patterns could be instrumental in better patient care and management. MATERIALS & METHODS : In this study, we evaluated the virulence determinants and antimicrobial susceptibility patterns of 100 clinical isolates of E. coli collected from extraintestinal infections and 50 control strains of E. coli. Hemolysin production, serum resistance, cell surface hydrophobicity, and gelatinase production were tested using standard laboratory procedures. RESULTS : Results showed that E. colistrains have a variable pattern of virulence markers that included hemolysin production (9%), cell surface hydrophobicity (9%), serum resistance (93%), and gelatinase production (2%). Antimicrobial susceptibility testing revealed a higher rate of resistance against cephalothin (84%) and ampicillin (98%). Susceptibility to amikacin (80%) and co-trimoxazole (47%) was variable and none of the test strains revealed resistance to imipenem. The control strains in contrast exhibited fewer virulence factors and the least resistance to antibiotics. CONCLUSION : In conclusion, the study results revealed that E. coli isolated from extraintestinal infections had demonstrated greater virulence and higher resistance to antibiotics as compared to the E. coli strains isolated from healthy individuals.
从患者管理的角度来看,鉴定临床分离微生物中的毒力决定因素具有更重要的意义。在住院患者中,年龄极端的人群(新生儿和老年患者)、因其他相关疾病而虚弱的患者、接受免疫抑制治疗的患者以及接受大手术的患者容易感染以前无致病性或机会性的病原体。筛选此类细菌的致病潜力并确定其毒力因子和抗菌药敏模式有助于更好地护理和管理患者。
在本研究中,我们评估了从肠外感染中收集的100株临床分离大肠杆菌和50株对照大肠杆菌菌株的毒力决定因素和抗菌药敏模式。使用标准实验室程序检测溶血素产生、血清抗性、细胞表面疏水性和明胶酶产生。
结果表明,大肠杆菌菌株具有可变的毒力标记模式,包括溶血素产生(9%)、细胞表面疏水性(9%)、血清抗性(93%)和明胶酶产生(2%)。抗菌药敏试验显示对头孢噻吩(84%)和氨苄西林(98%)的耐药率较高。对阿米卡星(80%)和复方新诺明(47%)的敏感性各不相同,且受试菌株均未显示对亚胺培南耐药。相比之下,对照菌株显示出较少的毒力因子和最低的抗生素耐药性。
总之,研究结果表明,与从健康个体分离的大肠杆菌菌株相比,从肠外感染中分离的大肠杆菌表现出更强的毒力和更高的抗生素耐药性。